Clinical and Trichoscopic Analysis of PRP Versus GFC for Male and Female Pattern Hair Loss

This article discusses nonprescription treatments for hereditary pattern hair loss, highlighting minoxidil's role and guidelines for use, but reports no new clinical results.

This article reviews various causes and treatments for alopecia, including nutritional deficiencies, stress, and hormonal changes, and reports no new clinical results.

This chapter reviews diffuse hair loss conditions like androgenetic alopecia, lichen planopilaris, telogen effluvium, and alopecia areata, but it provides no new clinical findings.

This study found no significant immediate hair growth or loss reduction from PRP treatment compared to Finastride and placebo, but differences emerged after three to six months.

In this study, researchers found that homologous PRP (h-PRP) significantly increased hair density more than both nonactivated (n-PRP) and activated (a-PRP) autologous PRP in patients with androgenetic alopecia, suggesting h-PRP as a potentially more effective treatment option for hair loss.

This article discusses various causes and prevention methods for male pattern baldness but reports no new research findings.